Related Experiment Videos

Hyperhomocysteinemia and thrombosis

M Makris1

  • 1Division of Molecular and Genetic Medicine, Royal Hallamshire Hospital, Sheffield, UK.

Insights

Patients with homocystinuria face higher risks of blood clots. While vitamins can lower homocysteine levels, their impact on the disease

Area of Science:

  • Cardiovascular Science
  • Metabolic Disorders
  • Hematology

Background:

  • Homocystinuria is linked to elevated homocysteine levels.
  • Elevated homocysteine is a known risk factor for thrombosis.
  • Moderate homocysteine increases correlate with venous and arterial thrombotic events.

Purpose of the Study:

  • To review the association between homocysteine levels and thrombotic risk.
  • To discuss the potential of vitamin therapy to mitigate these risks.

Main Methods:

  • Literature review of studies on homocystinuria and thrombosis.
  • Analysis of the effects of folic acid, vitamin B12, and vitamin B6 on homocysteine levels.

Main Results:

  • Patients with homocystinuria have a significantly increased risk of venous and arterial thrombosis.
  • Moderate elevations in homocysteine are associated with deep vein thrombosis, myocardial infarction, cerebral infarction, and peripheral vascular disease.
  • Vitamin therapy (folic acid, B12, B6) can effectively reduce homocysteine levels.

Conclusions:

  • Elevated homocysteine is a critical risk factor for vascular events in homocystinuria.
  • While vitamin supplementation normalizes homocysteine levels, its effect on altering the disease's natural progression remains unproven.

Related Concept Videos